Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

(2012) J. E. Levine et al.   BLOOD

Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD

(2012) J. E. Croudace et al.   BLOOD

Advances in predicting acute GVHD

(2012) Andrew C. Harris et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis

(2012) Wei Liu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

(2011) J. L. M. Ferrara et al.   BLOOD

CXCR3 ligands: redundant, collaborative and antagonistic functions

(2011) Joanna R Groom et al.   IMMUNOLOGY AND CELL BIOLOGY

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

(2010) S. Sarantopoulos et al.   BLOOD

Differential chemokine expression in chronic GVHD of the conjunctiva

(2010) H Westekemper et al.   BONE MARROW TRANSPLANTATION

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors

(2009) J. Koreth et al.   BLOOD

Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa

(2009) M. M. Imanguli et al.   BLOOD

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

(2009) S. Sarantopoulos et al.   BLOOD

A biomarker panel for acute graft-versus-host disease

(2008) S. Paczesny et al.   BLOOD

CXCL9, but not CXCL10, Promotes CXCR3-Dependent Immune-Mediated Kidney Disease

(2008) J. Menke et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group

(2007) H. Fujii et al.   BLOOD